Metastatic hepatocellular carcinoma: When, how, where and so what?

Liver International

Volumn 28, Issue 9, 2008, Pages 1183-1185

  Huo, Teh Ia ^a,b   Lin, Han Chieh ^a,b  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA FETOPROTEIN; CORE PROTEIN; DECARBOXYPROTHROMBIN; HEPATITIS B VIRUS X PROTEIN; HYPOXIA INDUCIBLE FACTOR 1ALPHA; KALININ; NONSTRUCTURAL PROTEIN 5A; OSTEOPONTIN; P21 ACTIVATED KINASE; TRANSFORMING GROWTH FACTOR BETA1; TUMOR MARKER; VASCULOTROPIN;

ADVANCED CANCER; BONE METASTASIS; BRAIN METASTASIS; CANCER RECURRENCE; CARCINOGENESIS; CELL DIFFERENTIATION; CHROMOSOME 8P; CHRONIC HEPATITIS; DISEASE ASSOCIATION; EDITORIAL; EPITHELIAL MESENCHYMAL TRANSITION; GENE OVEREXPRESSION; HEPATITIS B; HEPATITIS C; HETEROZYGOSITY LOSS; HUMAN; LIVER CELL CARCINOMA; LUNG METASTASIS; METASTASIS; PHENOTYPE; PROTEIN EXPRESSION; RISK FACTOR;

CARCINOMA, HEPATOCELLULAR; HUMANS; LIVER NEOPLASMS; NEOPLASM METASTASIS; RISK FACTORS;

EID: 51649096448     PISSN: 14783223     EISSN: 14783231     Source Type: Journal    
DOI: 10.1111/j.1478-3231.2008.01863.x     Document Type: Editorial

References (20)

1. Hanazaki K, Kajikawa S, Koide N, Adachi W, Amano J. Prognostic factors after hepatic resection for hepatocellular carcinoma with hepatitis C viral infection: Univariate and multivariate analysis. Am J Gastroenterol 2001; 96: 1243-50.
2. Kim BK, Han KH, Park YN, et al. Prediction of microvascular invasion before curative resection of hepatocellular carcinoma. J Surg Oncol 2008; 97: 246-52.
3. Kanda M, Tateishi R, Yoshida H, et al. Extrahepatic metastasis of hepatocellular carcinoma: Incidence and risk factors. Liver Int 2008; 28: 1256-63.
4. Koike K. Hepatitis B virus HBx gene and hepatocarcinogenesis. Intervirology 1995; 38: 134-42.
5. Tanaka N, Moriya K, Kiyosawa K, et al. PPARalpha activation is essential for HCV core protein-induced hepatic steatosis and hepatocellular carcinoma in mice. J Clin Invest 2008; 118: 683-94.
6. Kim BK, Park JY, Kim do Y, et al. Persistent hepatitis B viral replication affects recurrence of hepatocellular carcinoma after curative resection. Liver Int 2008; 28: 393-401.
7. Sasaki A, Kai S, Endo Y, et al. Hepatitis B virus infection predicts extrahepatic metastasis after hepatic resection in patients with large hepatocellular carcinoma. Ann Surg Oncol 2007; 14: 3181-7.
8. Ikeda K, Arase Y, Saitoh S, et al. Interferon beta prevents recurrence of hepatocellular carcinoma after complete resection or ablation of the primary tumor - a prospective randomized study of hepatitis C virus-related liver cancer. Hepatology 2000; 32: 228-32.
9. 2 - terminal kinase activation and paxillin phosphorylation. Cancer Res 2007; 67: 3601-8.
10. Pan HW, Ou YH, Peng SY, et al. Overexpression of osteopontin is associated with intrahepatic metastasis, early recurrence, and poorer prognosis of surgically resected hepatocellular carcinoma. Cancer 2003; 98: 119-27.
11. Chao Y, Li CP, Chau GY, et al. Prognostic significance of vascular endothelial growth factor, basic fibroblast growth factor, and angiogenin in patients with resectable hepatocellular carcinoma after surgery. Ann Surg Oncol 2003; 10: 355-62.
12. Lee TK, Poon RT, Yuen AP, et al. Rac activation is associated with hepatocellular carcinoma metastasis by up-regulation of vascular endothelial growth factor expression. Clin Cancer Res 2006; 12: 5082-9.
13. Giannelli G, Bergamini C, Fransvea E, Sgarra C, Antonaci S. Laminin-5 with transforming growth factor-beta1 induces epithelial to mesenchymal transition in hepatocellular carcinoma. Gastroenterology 2005; 129: 1375-83.
14. Lee TK, Poon RT, Yuen AP, et al. Twist overexpression correlates with hepatocellular carcinoma metastasis through induction of epithelial-mesenchymal transition. Clin Cancer Res 2006; 12: 5369-76.
15. Niu RF, Zhang L, Xi GM, et al. Up-regulation of Twist induces angiogenesis and correlates with metastasis in hepatocellular carcinoma. J Exp Clin Cancer Res 2007; 26: 385-94.
16. Budhu A, Forgues M, Ye QH, et al. Prediction of venous metastases, recurrence, and prognosis in hepatocellular carcinoma based on a unique immune response signature of the liver microenvironment. Cancer Cell 2006; 10: 99-111.
17. Lu T, Hano H. Identification of minimal regions of deletion at 8p23.1-22 associated with metastasis of hepatocellular carcinoma. Liver Int 2007; 27: 782-90.
18. Yen FS, Wu JC, Lai CR, et al. Clinical and radiological pictures of hepatocellular carcinoma with intracranial metastasis. J Gastroenterol Hepatol 1995; 10: 413-8.
19. Sasaki Y, Imaoka S, Shibata T, et al. Successful surgical management of pulmonary and adrenal metastases from hepatocellular carcinoma. Eur J Surg Oncol 1991; 17: 84-90.
20. Llovet JM, Bruix J. Novel advancements in the management of hepatocellular carcinoma in 2008. J Hepatol 2008; 48(Suppl. 1): S20-37.